GE HealthCare Beats Profit Estimates on Strong Imaging Demand and Tariff Refunds

GE HealthCare exceeded fourth-quarter profit expectations, supported by robust demand for imaging equipment and tariff refunds. The company boosted revenues, particularly due to increased demand for medical imaging devices. Additionally, partial refunds of tariffs paid in prior periods positively contributed to profitability. According to the company, adjusted earnings per share came in at $1.14, surpassing analysts' estimate of $1.07. Revenues reached $5.1 billion, slightly below expectations. However, profit margins improved thanks to strong demand and cost control. GE HealthCare noted increased demand, especially for magnetic resonance (MR) and computed tomography (CT) devices. The company anticipates continued growth driven by innovations in these products and ongoing healthcare investments. It was also emphasized that the tariff refunds are one-time in nature, but operational efficiency will be maintained. Analysts assess that GE HealthCare could continue to perform well in the coming period due to its strong product portfolio and growth potential in the healthcare sector. However, they caution about macroeconomic uncertainties and supply chain issues. This is not investment advice.